The effects of research and development expense, promotion and distribution expense, training expense, return on equity and gross domestic product on stock return before and during the covid-19: evidence form Indonesian pharmaceutical companies for Q1 2010-Q2 2021

About Us

Ipmi Repository is an online archive service which is managed by IPMI Library - Learning Resource Center. Established for collecting, managing, saving, preserving and disseminating digital copies of intellectual output of IPMI International Business School such as academic journal, books, theses, Group Field Project, Community Involvement Project, Case Study, conference paper, and other types of research publication. The main objective of this repository is to provide long-term, public, open access and easily retrieve to the digital collection to support teaching-learning process.

"Knowledge without observation is nil"

Sidarta, Anneke (2021) The effects of research and development expense, promotion and distribution expense, training expense, return on equity and gross domestic product on stock return before and during the covid-19: evidence form Indonesian pharmaceutical companies for Q1 2010-Q2 2021. Undergraduate thesis, IPMI Business School.

Text
Anneke Sidarta - The effect of research and development expense.pdf
Restricted to Registered users only
Download (1MB)

Abstract

The need of costs of research and development (R&D), promotion and distribution, training are very crucial for pharmaceutical companies. These costs influence the company's performance that will impact its share return especially if there is an extraordinary condition that emerged from the macro environment, such as the Covid-19 pandemic. The objective of the study will measure and evaluate the impact of these costs, as independent variables toward the share return as the dependent variable. In Kalbe Farma Tbk, the cost of training for Q4 2020 is 163% compared with Q3 2020, however, the share return and income showed inconsistency for this period. The share return is minus five and the return of equity is higher compared with Q3 2020. There were two pharmaceutical companies listed in the Jakarta stock exchange as the objects. The quarterly data are taken from the financial reports Q1 2010 - Q2 2021. The financial reports show that there is a gap between those cost-share returns and income.

Item Type:	Thesis (Undergraduate)
Subjects:	H Social Sciences > H Social Sciences (General) H Social Sciences > HB Economic Theory
Divisions:	Thesis > Master of Business Administration
Depositing User:	Dede Faujiah
Date Deposited:	24 Jan 2022 07:41
Last Modified:	24 Jan 2022 07:41
URI:	http://repository.ipmi.ac.id/id/eprint/1368

Actions (login required)

View Item